Texas Instruments Just Ripped 31% — Now Comes the Hard Part

Texas Instruments has spent the summer doing something it rarely does: getting exciting. A stock that built its reputation on being the boring, steady analog dividend payer just ran up roughly 31% in 30 days, got a Zacks #1 Strong Buy stamp, and drew an eye-popping upgrade from Arete Research to a $405 target. For a company whose pitch used to be "we make chips that go in your thermostat," that's a hell of a glow-up. The question now is whether the fundamentals actually caught up to the narrative — or whether Wall Street just decided TI deserves an AI multiple because everything with a chip inside it does these days.

Start with what's real. TI's Q2 FY2026 print, reported back in June, was genuinely strong: revenue of $5.46 billion, up 23% year-over-year, with data-center revenue nearly doubling on AI power demand. Free cash flow surged 154% to $4.35 billion, pushing FCF margins to 23.6%. Industrial and automotive — the two end markets that spent 2023–2024 in a demand ditch — are re-accelerating. That's not vapor. TI's "counter-cyclical" inventory strategy, where it kept building capacity while everyone else retrenched, looks like it's paying off exactly as management said it would.

Here's where it gets messier. Depending on which lens you use, TXN trades anywhere from 35x forward earnings to nearly 50x trailing — a spread wide enough to drive a truck through, and a clear sign the market is arguing with itself about what this stock actually is. Is it a steady 8–10% grower that deserves a market multiple, or an AI-infrastructure beneficiary that deserves a growth multiple? The rally says the market has already voted for door number two. The analyst tape says otherwise: one tally shows a flat "Hold" consensus (4 buys, 5 holds, 4 sells) even as another source flags a Strong Buy rank. That's not noise — that's real, unresolved disagreement among people paid to have an opinion.

And the price targets are almost comically split. One 2026 framework put a bull case at $225 and a bear case at $114 — both of which sit below or barely above today's ~$276 price, which tells you that model hasn't been updated since before the rally. A newer read puts the range at $225 to $405. Our internal numbers land closer to a $230.91 bear, $287.87 base, and $352.50 bull over three months. Translation: nobody agrees on the ceiling, but there's growing agreement the floor is lower than where the stock sits today.

That's the part I'd actually worry about. Jefferies quietly raised TI's "acceptable" inventory range from 130–200+ days up to 150–250 days. Companies don't widen inventory tolerance bands because demand is roaring — they do it because they're bracing for a slower sell-through and don't want the next earnings call to look like a write-down panic. Layer on the $7.5 billion Silicon Labs acquisition, which adds net debt before a single dollar of synergy shows up, and you've got a company simultaneously telling you demand is great and hedging against demand not being great. And don't sleep on the China angle — domestic analog players like SinoMOS and Chipsea are chipping away at the commodity end of TI's business, the part that doesn't get a press release but shows up in gross margin over time.

So where does that leave us heading into the October 27 earnings date (and a couple of industry confabs in Munich and San Francisco this week that are more about mindshare than material catalysts)? TXN is a good company that got priced, almost overnight, for flawless execution. The AI-data-center growth story is real, the FCF inflection is real, and the industrial/auto recovery is real. But "priced for execution" cuts both ways — at these multiples, TI doesn't get credit for good quarters, it gets punished for merely fine ones. If Q3 confirms the inventory buildup was prudent and not defensive, this thing has room to run toward the upper targets. If it confirms the opposite, $230 stops looking like a bear case and starts looking like a floor. Either way, October 27 is the date that settles the argument the analysts clearly haven't.